⚠ Evidence warning: Clinical trials or other evidence do not support the claim that bone broth heals a leaky gut or helps irritable bowel syndrome, small intestinal bacterial overgrowth, inflammatory bowel disease, autism or gut damage from anti-inflammatory painkillers; no human trial of bone broth for these conditions was found, and the only bone-broth colitis study is in mice. This page keeps it as a report of what people, websites or other media say.
Bone Broth for Gut Healing
Bone broth is the cornerstone food of every modern gut-healing protocol — the GAPS Diet, the Specific Carbohydrate Diet (SCD), the Autoimmune Protocol (AIP), and the Weston A. Price Foundation's "nourishing traditions" framework all center daily broth consumption. The mechanism is the convergence of three components — gelatin-derived peptides that signal mucin-producing goblet cells, free glycine that supports the gut's heavy demand for one-carbon metabolism, and free glutamine that is the preferred fuel for enterocytes — arriving simultaneously in a warm, easily digested vehicle. This deep-dive walks through the "leaky gut" intestinal-permeability framework, the mechanism of each broth component, the historical convalescence-soup tradition that long predates modern gastroenterology, and how bone broth is used within gut-healing protocols.
Table of Contents
- The Convalescence-Soup Tradition
- The "Leaky Gut" / Intestinal Permeability Framework
- Gelatin and the Mucin Layer
- Glycine and the Gut
- Glutamine and the Enterocyte
- Tight Junctions and Zonulin
- The Weston A. Price Foundation Revival
- Integrating Broth into a Gut-Healing Protocol
- A Caution: Histamine Intolerance
- Practical Recipes and Quantity Guidance
- Key Research Papers
- Connections
- Featured Videos
The Convalescence-Soup Tradition
Every traditional cuisine has its convalescent broth. The Jewish grandmother's chicken soup. The French consommé. The Chinese long-simmered pork-bone broth (tonkotsu — later popularized as ramen base in Japan). The Vietnamese phở and its overnight beef-bone simmer. The South Korean seolleongtang ox-bone broth that simmers for over twelve hours until the liquid turns milky. The Italian brodo. The Mexican caldo de res and caldo de pollo served to the sick and to postpartum mothers. The English beef-tea given to Victorian-era invalids.
The convergence is not coincidence. Across cultures with no contact, the food given to a person recovering from acute illness, surgery, or childbirth is the same: a long-simmered bone broth, often clear or only lightly thickened, sometimes with a small portion of soft-cooked rice or noodles, sometimes with herbs traditionally believed to support recovery. The reason is empirical. When a person has been too ill to eat solid food for days, the bone broth is what they tolerate first — warm, salty, calorically modest, and rich in the amino acids the body has been catabolizing during the illness.
In the same tradition, bone broth has long been given to undernourished children who are too unwell to eat much else, valued as a source of calcium and amino acids.
For the modern gut-healing application, the convalescence-soup tradition matters because the patient with severe irritable bowel syndrome (IBS), small intestinal bacterial overgrowth (SIBO), inflammatory bowel disease (IBD), or post-infectious gastroenteritis is functionally in a state of chronic convalescence. The gut needs what the convalescent gut has always needed — warm, easily absorbed, calorically dense (when emulsified with fat), amino-acid-rich liquid feeding while the mucosa heals.
The "Leaky Gut" / Intestinal Permeability Framework
"Leaky gut syndrome" is the popular shorthand for what gastroenterologists call increased intestinal permeability. The intestinal epithelium is a single layer of columnar cells — one cell thick — sitting between the contents of the gut lumen (food, bacteria, bacterial fragments, dietary toxins) and the body's interior. The integrity of this layer is maintained by tight-junction protein complexes (claudins, occludin, zonula occludens-1 (ZO-1), junctional adhesion molecule A (JAM-A)) that physically seal the gaps between adjacent enterocytes.
When tight-junction integrity is disrupted — by chronic inflammation, nonsteroidal anti-inflammatory drug (NSAID) use, alcohol, dysbiotic bacterial overgrowth, glyphosate exposure, gluten in genetically susceptible individuals, severe psychological stress, or simply prolonged poor nutrition — the paracellular space between enterocytes opens. Bacterial lipopolysaccharide (LPS, endotoxin), partially digested food proteins, and bacterial metabolites cross the barrier and trigger systemic immune activation. This is the mechanistic core of the "leaky gut" framework.
The clinical syndromes most strongly associated with documented increased intestinal permeability include:
- Inflammatory bowel disease (Crohn's, ulcerative colitis) — permeability is elevated in active disease and often persists during remission
- Celiac disease and non-celiac gluten sensitivity — gliadin peptides directly trigger zonulin release, which opens tight junctions
- Irritable bowel syndrome (IBS), particularly post-infectious irritable bowel syndrome — permeability remains elevated for months after a triggering gastroenteritis
- small intestinal bacterial overgrowth (SIBO) — the bacteria displaced into the small bowel produce endotoxin and short-chain fatty acids that compromise barrier function
- Autoimmune conditions in general — Hashimoto's, rheumatoid arthritis, lupus, type 1 diabetes, multiple sclerosis all show increased permeability as a common upstream feature
- Nonsteroidal anti-inflammatory drug enteropathy — chronic nonsteroidal anti-inflammatory drug use opens the small-bowel barrier within weeks, and the effect is dose-dependent
The mainstream gastroenterology position has shifted in the past decade from skepticism of the "leaky gut" concept to acceptance of the underlying permeability biology, with some lingering disagreement about the clinical utility of measuring permeability and about the causal direction (does permeability drive disease, or is it a consequence of underlying inflammation?). The bone-broth-as-gut-healing argument does not require the most aggressive version of the framework — it requires only the modest claim that providing the substrates needed for mucosal repair (gelatin-derived peptides, free glycine and glutamine, mineral support) can help the gut do what it is already trying to do.
A 2025 review of bone broth's nutrients drew on animal and human studies of its individual components — the amino acids glutamine, glycine, proline, histidine and arginine, and the minerals calcium, phosphorus, potassium, magnesium and zinc. The authors concluded that the documented benefits of these components support gut-barrier function and reduce inflammation in the intestinal barrier, particularly in inflammatory bowel disease, and they called for further research on bone broth itself.
Gelatin and the Mucin Layer
The intestinal epithelium does not face the gut lumen naked. Sitting on top of the enterocyte layer is the mucin layer — a thick gel produced by goblet cells in the epithelium. The mucin layer is the first line of physical defense against bacterial and chemical insult. Disruption of mucin production is an early event in inflammatory bowel disease and a contributor to bacterial translocation across the barrier.
The principal small-intestinal mucin is Muc2 (a secreted gel-forming mucin); the principal colonic mucin is also Muc2 with significant Muc1 (membrane-tethered) contribution. Mucins are heavily glycosylated proteins built on an amino-acid backbone dominated by serine, threonine, and proline — the three amino acids that accept O-linked glycan chains. Mucin synthesis is therefore particularly demanding of these amino acids.
Gelatin from bone broth contributes to mucin synthesis in two ways. First, the gelatin matrix is approximately 22% proline plus hydroxyproline by weight — a much higher proline content than most other dietary protein sources. Second, the prolyl-hydroxyproline dipeptides released from gelatin during digestion appear to have signaling effects on epithelial cells beyond their value as raw substrate. Animal studies of gelatin and collagen-peptide feeding show measurable increases in mucin synthesis, goblet-cell density, and barrier resistance to challenge with bacterial toxins or chemical irritants like dextran sodium sulfate (the standard rodent model of colitis).
The clinical translation in humans is at the level of plausibility and case-series, not large randomized trials. The Mar-Solís 2021 paper in Medicina was a mouse study: mice drank beef-femur bone broth freely for 10 days before colitis was induced chemically. Giving the broth beforehand reduced tissue damage in the colon and cut the expression of the inflammatory signals interleukin-1 beta (IL-1β), interleukin-6 (IL-6) and tumor necrosis factor alpha (TNF-α) by 61.12%, 94.70% and 68.88%. No trial of bone broth in people with ulcerative colitis has been published. The mechanistic logic is sound and the safety profile of broth is essentially perfect, so the case for broth rests on a combination of mechanism, tradition and animal results rather than human trials.
Glycine and the Gut
The gut is the single largest consumer of glycine in the body, for multiple overlapping reasons. Glycine is one of the three amino acids in glutathione (reduced glutathione (GSH) = glutamate + cysteine + glycine), the principal endogenous antioxidant and detoxifier; the gut epithelium has extremely high glutathione turnover because it is constantly exposed to dietary oxidants, bacterial toxins, and reactive oxygen species. Glycine is the substrate for bile-acid conjugation to glycocholate and glycochenodeoxycholate; the small intestine recycles approximately 95% of bile acids via the enterohepatic circulation, and the glycine load to support this is substantial.
Beyond these substrate roles, glycine has direct anti-inflammatory effects mediated through glycine-gated chloride channels expressed on macrophages, T cells, and Kupffer cells. Activation of these channels hyperpolarizes the inflammatory cells and reduces their cytokine output. Animal models of nonsteroidal anti-inflammatory drug enteropathy, alcohol-induced gut injury, and ischemia-reperfusion injury show consistent protective effects of pretreatment with oral or intravenous (IV) glycine.
Bone broth delivers approximately 1-2 g of glycine per cup, with substantial variability depending on the bones used (joint bones and skin yield more), the simmer time (longer extracts more gelatin), and the resulting gel strength. For comparison, Meléndez-Hevia and colleagues (2009, Journal of Biosciences) compared all reported figures for glycine production and use in a human adult: the body makes about 3 g of glycine per day and the diet supplies 1.5-3.0 g per day, which may fall short of total metabolic needs, collagen synthesis included, by about 10 g per day for a 70 kg person. This is a calculation from published figures, not a trial. The authors conclude that glycine is a semi-essential amino acid.
Bone broth itself is an unreliable source of these amino acids. A laboratory analysis of bone broths found that broth made to a standard recipe contained significantly less glycine, proline and hydroxyproline than a 20 g dose of the collagen supplements used in research. Broths made to non-standard home and café recipes varied widely, the café broths had the highest levels, and among standardized preparations the commercial broths were lower in every amino acid measured than the home-prepared ones.
For a more comprehensive treatment of glycine biochemistry and its role beyond the gut — including the sleep, methylation, and aspirin-detox aspects — see our Glycine page.
Glutamine and the Enterocyte
Glutamine is the most abundant free amino acid in human plasma and the preferred fuel for rapidly dividing cells — especially enterocytes (small-intestinal absorptive cells), colonocytes (colonic absorptive cells), lymphocytes, and macrophages. The enterocyte derives a substantial fraction of its adenosine triphosphate (ATP) from glutamine oxidation, not from glucose. In states of metabolic stress (sepsis, trauma, burn injury, post-surgical recovery, prolonged fasting), enterocyte glutamine demand outstrips supply, and barrier function suffers as a consequence.
The clinical evidence base for glutamine and gut barrier function is more developed than for any other broth component, because pharmaceutical-grade L-glutamine has been studied as an isolated intervention in critical-care medicine for decades. A 2008 review reported that meta-analyses up to then showed glutamine supplementation reducing mortality, length of stay and infectious complications in critical illness. Two large randomized trials since then did not confirm this. In a 2013 trial of 1223 critically ill adults with multiorgan failure in intensive care units (ICUs), glutamine given both intravenously and through the gut had no effect on organ failure or infectious complications, and in-hospital and 6-month mortality were significantly higher with glutamine. In a 2022 trial that analysed 1200 patients with severe burns, enteral glutamine at 0.5 g per kilogram of body weight per day did not shorten the time to discharge alive from hospital (median 40 days with glutamine versus 38 days with placebo), and 6-month mortality was 17.2% with glutamine versus 16.2% with placebo. In less acute settings, glutamine has been tested for inflammatory bowel disease, diarrhea-predominant irritable bowel syndrome (IBS-D), chemotherapy-induced mucositis, post-bariatric leaky gut, and athlete overtraining gut symptoms, with generally positive but inconsistent results.
Bone broth delivers modest amounts of free glutamine — roughly 100-300 mg per cup of well-made broth, far less than the 5-30 g daily doses used in clinical trials. So broth alone does not reach the amounts used in clinical glutamine trials, which used powdered L-glutamine. The role of broth is gentler, ongoing baseline support of enterocyte metabolism in a vehicle that also delivers the gelatin peptides, glycine, and minerals discussed above.
For deeper discussion of glutamine as a standalone supplement and its evidence base in inflammatory bowel disease and post-infectious irritable bowel syndrome, see our Glutamine page and the Glutamine for Gut Health deep-dive.
Tight Junctions and Zonulin
The protein machinery that physically seals the gaps between enterocytes consists of tight-junction proteins arranged in a circumferential belt at the apical pole of each cell. The principal proteins are claudins (a family of more than twenty isoforms with cell-type-specific expression), occludin, junctional adhesion molecules (JAMs), and intracellular scaffolding proteins (ZO-1, ZO-2). Disruption of any of these proteins increases paracellular permeability.
The regulatory molecule that controls tight-junction opening is zonulin, identified by Dr. Alessio Fasano's group at the University of Maryland School of Medicine. Zonulin is released by enterocytes in response to two main triggers: gliadin (the alcohol-soluble fraction of gluten in wheat, barley, and rye) and luminal exposure to certain bacterial species. Zonulin release transiently opens tight junctions — a normal physiological process to allow regulated paracellular transport — but chronic zonulin elevation, as in celiac disease, non-celiac gluten sensitivity, and several autoimmune conditions, produces sustained barrier dysfunction.
The bone-broth contribution to tight-junction integrity is indirect rather than direct. Broth does not block zonulin signaling or directly insert tight-junction proteins. What broth provides is the amino-acid substrate (glycine, proline, threonine, serine) for the protein synthesis the enterocyte needs to rebuild damaged tight-junction complexes, plus the enterocyte fuel (glutamine) to power that synthesis, plus the mucin substrate (gelatin peptides) to maintain the protective gel layer above the epithelium. In this framework, removing the upstream trigger (for example, a strict gluten-free trial in suspected non-celiac gluten sensitivity) comes first, and broth is described as supporting the repair that follows.
For deeper treatment of the gut-barrier framework as a clinical entity, see our Gut Healing page and the gluten-free practical guide.
The Weston A. Price Foundation Revival
The modern bone-broth revival in the English-speaking world is largely traceable to the Weston A. Price Foundation (WAPF), founded in 1999 by Sally Fallon Morell and Mary Enig, and to Fallon's cookbook Nourishing Traditions (first edition 1995, expanded 1999). The WAPF mission is to revive and disseminate the dietary traditions that Dr. Weston A. Price, a Cleveland dentist, documented in his 1939 book Nutrition and Physical Degeneration — the result of his decade-long travels studying isolated traditional populations (Swiss alpine villagers, Outer Hebrides islanders, Inuit, Maasai, Aboriginal Australians, Pacific Islanders) who showed near-zero rates of dental caries and chronic Western disease while eating their ancestral diets.
Price's observation was that across these geographically isolated and culturally unrelated populations, the foods most prized for health — especially for pregnant and nursing women and growing children — were the nutrient-dense animal foods that modern Western eating had abandoned: organ meats, raw dairy from pastured animals, fish eggs and small whole fish, and bone broths. The WAPF revival of bone broth specifically draws on the universal traditional use of long-simmered bone stock as a foundational cooking liquid and convalescent food.
Sally Fallon's 1999 essay "Broth Is Beautiful" is the foundational document of the modern bone-broth revival in the alternative-medicine community. It introduced two generations of readers to the practical mechanics of making proper broth at home (vinegar in the cold-water start, 12-24 hour simmer, skimming the scum, freezing in ice-cube trays for cooking) and to the WAPF claim that broth's gelatin and mineral content make it a foundational food for digestive recovery, joint health, skin elasticity, and pediatric nutrition. The contemporary commercial bone-broth industry emerged downstream of the WAPF revival, with a bone-broth storefront in New York's East Village (opened 2014) widely credited as the moment bone broth crossed from alternative-health subculture to mainstream urban food culture.
For bone broth specifically, the WAPF case rests on four points — the safety is essentially perfect, the cost is low, the tradition is universal, and the mechanism is plausible even where the evidence from large randomized controlled trials is thin.
Integrating Broth into a Gut-Healing Protocol
Bone broth is rarely the entire intervention — it is the foundational food that supports whatever specific therapeutic strategy a patient is using. Common contexts:
- GAPS Diet (Gut and Psychology Syndrome, Natasha Campbell-McBride) — the Introduction Diet stages begin with bone broth as the primary food source, with vegetables, fermented foods, and animal protein added in stages over weeks. Broth is consumed multiple times daily, with fat and slow-cooked meat incorporated. Used in clinical practice for children with autism-spectrum disorders, severe irritable bowel syndrome, and food sensitivities, with a strong patient testimonial base and limited but suggestive published evidence.
- Specific Carbohydrate Diet (SCD, Elaine Gottschall) — the Introduction Diet phase centers homemade broth alongside soft-cooked meat and lactose-free yogurt, used historically for ulcerative colitis, Crohn's, celiac, and severe irritable bowel syndrome, with a small but real published evidence base in pediatric inflammatory bowel disease remission.
- Autoimmune Protocol (AIP) — an elimination diet that removes grains, legumes, dairy, eggs, nightshades, nuts, seeds, and processed foods for 30-90 days, with bone broth as a daily centerpiece during the elimination phase, then systematic reintroduction. Used widely for Hashimoto's, rheumatoid arthritis (RA), lupus, multiple sclerosis (MS), inflammatory bowel disease, with growing published evidence (the 2017 inflammatory bowel disease pilot at Scripps and a 2019 Hashimoto's pilot showing measurable inflammatory marker improvement).
- Small intestinal bacterial overgrowth treatment elemental diet bridge — for patients transitioning off a 2-3 week elemental diet used to treat small intestinal bacterial overgrowth, bone broth is often the first whole-food reintroduction, before solid food.
- Post-infectious irritable bowel syndrome recovery — after a triggering gastroenteritis episode, daily broth alongside a low-FODMAP (fermentable oligosaccharides, disaccharides, monosaccharides and polyols) transitional diet supports mucosal recovery while symptoms gradually resolve.
- Nonsteroidal anti-inflammatory drug enteropathy recovery — for patients required to remain on chronic nonsteroidal anti-inflammatory drug therapy (some rheumatology patients), daily broth provides ongoing substrate support for the constantly damaged small-bowel mucosa.
The integration pattern is consistent across protocols: 1-3 cups of broth daily, sipped warm, ideally with the dietary fat layer (skimmed-off tallow or schmaltz) incorporated for caloric density and fat-soluble vitamin absorption, alongside whatever specific dietary restriction the protocol requires.
A Caution: Histamine Intolerance
The single significant caution for bone-broth therapy in gut-healing contexts is histamine intolerance. Bone broth is high in histamine because the long simmer time and the protein hydrolysis it produces both favor histamine generation. Patients with histamine intolerance — a syndrome characterized by reduced diamine oxidase (DAO) activity in the small-intestinal brush border, often co-occurring with small intestinal bacterial overgrowth, mast cell activation syndrome (MCAS), or postural orthostatic tachycardia syndrome (POTS) — can experience flushing, headache, hives, anxiety, palpitations, or gastrointestinal (GI) symptoms after consuming high-histamine foods including bone broth.
Workarounds described for these patients:
- Short-simmer broth (4-6 hours instead of 24) — substantially reduces histamine generation while still yielding gelatin
- Pressure-cooker broth (2-3 hours under pressure) — achieves the gelatin extraction of a long simmer in less time, with lower histamine yield
- Fresh broth, never aged or frozen-thawed — histamine increases over time in stored broth; histamine-intolerant patients tolerate fresh broth better than refrigerated leftovers
- DAO supplementation 15 minutes before broth — commercial DAO enzyme supplements are used to blunt the histamine response
- Hydrolyzed collagen peptide powder as a histamine-free alternative — provides similar gelatin-derived peptides without the histamine burden, for patients who cannot tolerate broth at all
For most patients without histamine intolerance, broth is well-tolerated. The histamine caution matters because the same population most likely to benefit from gut-healing intervention (postural orthostatic tachycardia syndrome, mast cell activation syndrome, small intestinal bacterial overgrowth, post-infectious irritable bowel syndrome) is also the population most likely to have histamine intolerance, so the two often occur together.
Practical Recipes and Quantity Guidance
The basic bone-broth recipe is conserved across traditions:
- 2-3 pounds of bones (mixture of marrow bones for fat and joint bones for gelatin) — for beef, oxtail and knuckles are ideal; for chicken, feet and necks; for fish, heads and frames
- Cold water to cover, plus 1-2 tablespoons of apple cider vinegar (the acid helps demineralize the bones modestly)
- Optional aromatics: onion, garlic, celery, carrot, parsley, bay leaf, thyme — added in the last hour to avoid bitterness
- Simmer 12-24 hours for beef, 6-12 hours for chicken, 2-4 hours for fish — or use a pressure cooker for 2-3 hours to achieve similar extraction
- Skim foam in the first 30 minutes; strain through a fine mesh after simmering
- Cool to refrigerator temperature — the fat will solidify on top and can be skimmed (save for cooking) or stirred in
- A well-made batch will gel firmly when chilled — the visual confirmation of gelatin extraction
Amounts used in gut-healing protocols: 1-3 cups per day, sipped warm, ideally between meals or first thing in the morning on an empty stomach for maximum gut-mucosa contact time. For severe cases (early GAPS Intro, post-elemental small intestinal bacterial overgrowth transition) the dose may be 4-6 cups daily for a defined intensive period.
Commercial alternatives: Where home preparation is not feasible, frozen commercial bone broths are the usual substitute; their labels distinguish actual long-simmered bone broth from reconstituted stock concentrate with added gelatin. The shelf-stable boxed broths in most grocery stores are not the same product — they typically gel poorly or not at all, indicating low gelatin content.
Cost comparison: Home-made broth from grass-fed beef bones runs approximately $1-2 per cup. Commercial frozen runs $5-8 per cup. Hydrolyzed collagen peptide powder providing equivalent collagen content runs about $1-1.50 per serving. For pure gelatin-peptide delivery, the powder is cheaper and more concentrated; for the full convalescent-food experience with minerals, free amino acids, and the warm-liquid vehicle, home-made broth delivers all of these together.
Minerals and metals: A study of animal bone broths found that lowering the broth's pH from 8.38 to 5.32 (more acidic, as vinegar makes it) raised the extraction of calcium and magnesium 17.4-fold and 15.3-fold, and cooking for more than 8 hours extracted significantly more calcium and magnesium than shorter cooking. Even so, the calcium and magnesium in home-made or commercial broth came to less than 5% of the daily recommended levels per serving. Lead and cadmium were in the range of a few micrograms per serving, which the authors judged a minimal risk.
Key Research Papers
- Fasano A (2011). Zonulin and its regulation of intestinal barrier function: the biological door to inflammation, autoimmunity, and cancer. Physiological Reviews. — PubMed PMID: 21248165
- Mar-Solís LM et al. (2021). Analysis of the anti-inflammatory capacity of bone broth in a murine model of ulcerative colitis. Medicina. — PubMed PMID: 34833355
- Meléndez-Hevia E et al. (2009). A weak link in metabolism: the metabolic capacity for glycine biosynthesis does not satisfy the need for collagen synthesis. Journal of Biosciences. — PubMed PMID: 20093739
- Wischmeyer PE (2008). Glutamine: role in critical illness and ongoing clinical trials. Current Opinion in Gastroenterology. — PubMed PMID: 18301270
- Zhou Q et al. (2019). Randomised placebo-controlled trial of dietary glutamine supplements for postinfectious irritable bowel syndrome. Gut. — PubMed PMID: 30108163
- Hartog A et al. (2015). A potential role for regulatory T-cells in the amelioration of DSS induced colitis by dietary non-digestible polysaccharides. Journal of Nutritional Biochemistry. — PubMed PMID: 25498760
- Hsu DJ, Lee CW, Tsai WC, Chien YC (2017). Essential and toxic metals in animal bone broths. Food & Nutrition Research. — PubMed PMID: 28804437
- Konijeti GG et al. (2017). Efficacy of the Autoimmune Protocol Diet for Inflammatory Bowel Disease. Inflammatory Bowel Diseases. — PubMed PMID: 28858071
- Suskind DL, Wahbeh G, Cohen SA, Damman CJ, Klein J, Braly K, Shaffer M, Lee D (2016). Patients perceive clinical benefit with the specific carbohydrate diet for inflammatory bowel disease. Digestive Diseases and Sciences. — PubMed PMID: 27638834
- Cohen SA et al. (2014). Clinical and mucosal improvement with specific carbohydrate diet in pediatric Crohn disease. Journal of Pediatric Gastroenterology and Nutrition. — PubMed PMID: 24897165
- Hou JK et al. (2014). Diet and inflammatory bowel disease: review of patient-targeted recommendations. Clinical Gastroenterology and Hepatology. — PubMed PMID: 24107394
- Wagenaar CA et al. (2021). The effect of dietary interventions on chronic inflammatory diseases in relation to the microbiome. Nutrients. — PubMed PMID: 34579085
- Heyland D, Muscedere J, Wischmeyer PE, Cook D, Jones G, Albert M, Elke G, Berger MM, Day AG; Canadian Critical Care Trials Group (2013). A randomized trial of glutamine and antioxidants in critically ill patients. New England Journal of Medicine. — PubMed PMID: 23594003
- Heyland DK et al.; RE-ENERGIZE Trial Team (2022). A randomized trial of enteral glutamine for treatment of burn injuries. New England Journal of Medicine. — PubMed PMID: 36082909
- Alcock RD, Shaw GC, Burke LM (2019). Bone broth unlikely to provide reliable concentrations of collagen precursors compared with supplemental sources of collagen used in collagen research. International Journal of Sport Nutrition and Exercise Metabolism. — PubMed PMID: 29893587
- Matar A, Abdelnaem N, Camilleri M (2025). Bone broth benefits: how its nutrients fortify gut barrier in health and disease. Digestive Diseases and Sciences. — PubMed PMID: 40180691